Callan Family Office’s Leidos LDOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$653K Sell
6,345
-538
-8% -$71.4K 0.01% 725
2026
Q1
$1.07M Sell
6,883
-454
-6% -$81.5K 0.02% 544
2025
Q4
$1.32M Buy
7,337
+2,981
+68% +$565K 0.03% 458
2025
Q3
$823K Buy
4,356
+410
+10% +$71.4K 0.03% 414
2025
Q2
$623K Buy
3,946
+2,031
+106% +$300K 0.02% 522
2025
Q1
$258K Sell
1,915
-108
-5% -$15.1K 0.02% 462
2024
Q4
$291K Buy
+2,023
New +$337K 0.02% 489

Other funds holding LDOS

Callan Family Office's LDOS Position: Q2 2026 in Review

Callan Family Office reduced its Leidos (LDOS) stake by 7.8% in Q2 2026, selling an estimated $71.4K and leaving 6,345 shares worth $653K. The position accounts for 0.01% of the portfolio, ranked #725.

Callan Family Office first reported a position in LDOS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32M in Q4 2025. 775 funds tracked by Wall St. Rank hold LDOS as of Q2 2026.

  • Callan Family Office held 6,345 shares of Leidos worth $653K as of Q2 2026.
  • Callan Family Office sold 538 Leidos shares in Q2 2026, an estimated $71.4K.
  • Leidos made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #725 holding.
  • Callan Family Office first reported a position in Leidos in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Leidos position peaked at $1.32M in Q4 2025.
  • 775 funds tracked by Wall St. Rank held Leidos as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.